Patents/Assignees

ASCENDIS PHARMA GROWTH DISORDERS A/S

6 patents in portfolio

US12544428utility2026
Controlled-release CNP Agonists with Reduced Side-effects
0 cites
US12377133utility2025
Dry Pharmaceutical Formulations of CNP Conjugates
0 cites
US12239689utility2025
Controlled-release CNP Agonists with Low Initial NPR-B Activity
0 cites
US12156917utility2024
CNP Prodrugs with Carrier Attachment at the Ring Moiety
0 cites
US12083182utility2024
Controlled-release CNP Agonists with Increased NEP Stability
0 cites
US11564974utility2023
Combination Therapy with Controlled-release CNP Agonists
0 cites